Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Hamee
3134
River Eletec
6666
JP Stock MarketDetailed Quotes
5591 Avilen
- 889
- -11-1.22%
20min DelayTrading Dec 16 14:59 JST
5.43BMarket Cap48.00P/E (Static)
910High880Low26.60KVolume903Open900Pre Close23.73MTurnover424052wk High1.08%Turnover Ratio6.11MShares83652wk Low16.956EPS TTM2.19BFloat Cap4240Historical High48.00P/E (Static)2.47MShs Float836Historical Low18.52EPS LYR3.33%Amplitude--Dividend TTM11.72P/B100Lot Size--Div YieldTTM
Avilen Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | 6.69%58.27M | -46.87%54.61M | 102.79M |
| Net profit before non-cash adjustment | 46.65%162.35M | 31.39%110.7M | --84.26M |
| Total adjustment of non-cash items | -89.17%3.34M | 122.00%30.86M | --13.9M |
| -Depreciation and amortization | 26.83%7.92M | 9.29%6.25M | --5.72M |
| -Reversal of impairment losses recognized in profit and loss | --1.05M | --0 | ---- |
| -Disposal profit | --0 | --0 | --0 |
| -Net exchange gains and losses | 165.57%139K | -194.44%-212K | ---72K |
| -Other non-cash items | -123.26%-5.77M | 200.63%24.83M | --8.26M |
| Changes in working capital | -23.54%-107.43M | -1,979.27%-86.95M | --4.63M |
| -Change in receivables | -158.69%-105.68M | -104.11%-40.85M | ---20.02M |
| -Change in inventory | ---- | ---- | ---2.24M |
| -Change in payables | 129.73%863K | -109.77%-2.9M | --29.72M |
| -Provision for loans, leases and other losses | -135.27%-3.65M | --10.36M | --0 |
| -Changes in other current assets | 101.95%1.04M | -1,787.70%-53.55M | ---2.84M |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | |||
| Interest received (cash flow from operating activities) | 100.00%2K | 0.00%1K | 1K |
| Tax refund paid | -49.56%-45.46M | -104,700.00%-30.39M | -29K |
| Other operating cash inflow (outflow) | -1K | 0 | -5.5M |
| Operating cash flow | -47.10%12.81M | -75.10%24.22M | --97.26M |
| Investing cash flow | |||
| Net PPE purchase and sale | 41.12%-368K | 59.91%-625K | ---1.56M |
| Net intangibles purchase and sale | -680.55%-45.1M | ---5.78M | --0 |
| Net changes in other investments | ---- | 71.86%-3.56M | ---12.65M |
| Investing cash flow | -356.41%-45.47M | 29.87%-9.96M | ---14.21M |
| Financing cash flow | |||
| Net common stock issuance | 10,313.12%96.84M | -33.33%930K | --1.4M |
| Issuance fees | ---9.55M | --0 | ---- |
| Net other fund-raising expenses | ---2K | ---- | ---- |
| Financing cash flow | 9,286.56%87.3M | -33.33%930K | --1.4M |
| Net cash flow | |||
| Beginning cash position | 7.24%228M | 66.00%212.6M | --128.07M |
| Current changes in cash | 259.71%54.64M | -82.01%15.19M | --84.45M |
| Effect of exchange rate changes | -165.57%-139K | 194.44%212K | --72K |
| Cash adjustments other than cash changes | --1K | ---- | --1K |
| End cash Position | 23.90%282.5M | 7.24%228M | --212.6M |
| Free cash flow | -283.26%-32.66M | -81.38%17.82M | --95.7M |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |